Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 45   

Articles published

ARNA 2.76 +0.06 (2.22%)
price chart
South Korea's Ildong Pharma To License Arena Pharma Drug
29, 2012) - U.S.-based Arena Pharmaceuticals, Inc. has licensed its internally discovered thrombosis drug, temanogrel, to Seoul, Korea-based Ildong Pharmaceutical Co.
Vivus Or Arena: Who Has The Edge?
Two of the three major players in the treatment of obesity, VIVUS Inc. (NASDAQ:VVUS) and Arena Pharmaceuticals Inc. (NASDAQ:ARNA) released their financial results and provided an update on recent developments.
Prescription drug deaths: Two stories
Pete Jackson attended his brother-in-law's funeral along with his daughter, Emily, six years ago. He never dreamed it would be the last day of his daughter's life.
Amgen Therapy Slims Monkeys as Study Seeks Obesity Drug
Nov. 28 (Bloomberg) -- An antibody discovered by Amgen Inc. researchers reduces weight and increases glucose tolerance in monkeys, according to a study, potentially opening up a new approach for treating obesity and diabetes in humans.
Vivus Inc: This Hedge Fund Just Went Activist
And then there's Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and a few other competitors. Belviq is the major competition to Qsymia, and with far fewer contraindications, Belviq is more likely to be the first-prescribed drug between Qsymia and Bevliq ...
Hedge Funds Are Buying These 6 High-Growth Biotech Stocks
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): Focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
FSD Drugs Advance as Women Push for Equal Access
In July, investors raised $20 million for startup Sprout Pharmaceuticals, which hopes to succeed where Boehringer Ingelheim failed by bringing flibanserin through development phases to market.
Stocks soar on Black Friday; tech leads the way
MAP Pharmaceuticals spiked after the company announced that the Food and Drug Administration will review its experimental migraine drug Levadex.
Seattle's Living Computer Museum: not just for techies
"He's extremely passionate about this place," said Christina Siderius, a spokeswoman for Allen's company, Vulcan Inc. Allen is a collector of epic proportions, but he doesn't keep his toys locked away in a private vault; he likes to share. He has two ...
Indian board rejects AstraZeneca's patent plea on cancer drug
Natco and another domestic drugmaker, G. M. Pharma, had opposed the initial patent application for AstraZeneca quinazoline derivative.